vs

Side-by-side financial comparison of Bridgeline Digital, Inc. (BLIN) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.

Bridgeline Digital, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.5M, roughly 1.6× Bolt Biotherapeutics, Inc.). Bridgeline Digital, Inc. runs the higher net margin — -2.2% vs -265.2%, a 263.0% gap on every dollar of revenue. Over the past eight quarters, Bridgeline Digital, Inc.'s revenue compounded faster (1.4% CAGR vs -31.2%).

Bridgeline Digital, Inc. provides digital experience solutions including web content management, e-commerce platforms, marketing automation tools, and custom digital development services. It primarily serves small and medium-sized North American enterprises across retail, healthcare, education, and non-profit segments.

Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.

BLIN vs BOLT — Head-to-Head

Bigger by revenue
BLIN
BLIN
1.6× larger
BLIN
$3.9M
$2.5M
BOLT
Higher net margin
BLIN
BLIN
263.0% more per $
BLIN
-2.2%
-265.2%
BOLT
Faster 2-yr revenue CAGR
BLIN
BLIN
Annualised
BLIN
1.4%
-31.2%
BOLT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLIN
BLIN
BOLT
BOLT
Revenue
$3.9M
$2.5M
Net Profit
$-86.0K
$-6.6M
Gross Margin
66.1%
Operating Margin
-4.4%
-283.4%
Net Margin
-2.2%
-265.2%
Revenue YoY
3.2%
Net Profit YoY
86.4%
58.4%
EPS (diluted)
$-0.01
$-9.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLIN
BLIN
BOLT
BOLT
Q4 25
$3.9M
$2.5M
Q3 25
$3.9M
$2.2M
Q2 25
$3.8M
$1.8M
Q1 25
$3.9M
$1.2M
Q4 24
$3.8M
$0
Q3 24
$3.9M
$1.1M
Q2 24
$3.9M
$1.3M
Q1 24
$3.8M
$5.3M
Net Profit
BLIN
BLIN
BOLT
BOLT
Q4 25
$-86.0K
$-6.6M
Q3 25
$-365.0K
$-7.1M
Q2 25
$-789.0K
$-8.6M
Q1 25
$-730.0K
$-11.0M
Q4 24
$-634.0K
$-15.9M
Q3 24
$-432.0K
$-15.2M
Q2 24
$-305.0K
$-21.2M
Q1 24
$-602.0K
$-10.8M
Gross Margin
BLIN
BLIN
BOLT
BOLT
Q4 25
66.1%
Q3 25
65.7%
Q2 25
66.3%
Q1 25
67.5%
Q4 24
66.9%
Q3 24
68.7%
Q2 24
68.8%
Q1 24
66.4%
Operating Margin
BLIN
BLIN
BOLT
BOLT
Q4 25
-4.4%
-283.4%
Q3 25
-12.5%
-355.1%
Q2 25
-17.9%
-510.5%
Q1 25
-19.2%
-991.4%
Q4 24
-13.5%
Q3 24
-12.5%
-1441.1%
Q2 24
-9.7%
-1772.3%
Q1 24
-13.6%
-324.1%
Net Margin
BLIN
BLIN
BOLT
BOLT
Q4 25
-2.2%
-265.2%
Q3 25
-9.4%
-329.4%
Q2 25
-20.5%
-474.6%
Q1 25
-18.8%
-903.4%
Q4 24
-16.7%
Q3 24
-11.2%
-1330.1%
Q2 24
-7.7%
-1662.4%
Q1 24
-15.8%
-205.0%
EPS (diluted)
BLIN
BLIN
BOLT
BOLT
Q4 25
$-0.01
$-9.38
Q3 25
$-0.02
$-3.72
Q2 25
$-0.07
$-4.46
Q1 25
$-0.10
$-0.29
Q4 24
$-0.06
$-13.73
Q3 24
$-0.04
$-7.93
Q2 24
$-0.03
$-11.12
Q1 24
$-0.06
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLIN
BLIN
BOLT
BOLT
Cash + ST InvestmentsLiquidity on hand
$1.5M
$27.5M
Total DebtLower is stronger
$236.0K
Stockholders' EquityBook value
$9.6M
$26.5M
Total Assets
$15.7M
$56.7M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLIN
BLIN
BOLT
BOLT
Q4 25
$1.5M
$27.5M
Q3 25
$1.6M
$31.9M
Q2 25
$2.1M
$34.8M
Q1 25
$2.8M
$38.8M
Q4 24
$1.5M
$47.3M
Q3 24
$1.4M
$53.8M
Q2 24
$1.2M
$73.7M
Q1 24
$1.3M
$91.3M
Total Debt
BLIN
BLIN
BOLT
BOLT
Q4 25
$236.0K
Q3 25
$326.0K
Q2 25
$348.0K
Q1 25
$406.0K
Q4 24
$409.0K
Q3 24
$500.0K
Q2 24
$524.0K
Q1 24
$612.0K
Stockholders' Equity
BLIN
BLIN
BOLT
BOLT
Q4 25
$9.6M
$26.5M
Q3 25
$9.6M
$32.1M
Q2 25
$9.9M
$38.8M
Q1 25
$10.6M
$46.8M
Q4 24
$9.6M
$57.2M
Q3 24
$10.0M
$72.0M
Q2 24
$10.3M
$85.9M
Q1 24
$10.5M
$104.2M
Total Assets
BLIN
BLIN
BOLT
BOLT
Q4 25
$15.7M
$56.7M
Q3 25
$15.3M
$65.1M
Q2 25
$16.1M
$75.5M
Q1 25
$17.0M
$85.9M
Q4 24
$15.5M
$99.6M
Q3 24
$15.6M
$109.3M
Q2 24
$16.0M
$124.2M
Q1 24
$16.3M
$142.9M
Debt / Equity
BLIN
BLIN
BOLT
BOLT
Q4 25
0.02×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLIN
BLIN
BOLT
BOLT
Operating Cash FlowLast quarter
$-39.0K
$-7.2M
Free Cash FlowOCF − Capex
$-46.0K
FCF MarginFCF / Revenue
-1.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLIN
BLIN
BOLT
BOLT
Q4 25
$-39.0K
$-7.2M
Q3 25
$-345.0K
$-9.7M
Q2 25
$-565.0K
$-9.6M
Q1 25
$-372.0K
$-13.4M
Q4 24
$178.0K
$-14.4M
Q3 24
$217.0K
$-14.0M
Q2 24
$0
$-16.1M
Q1 24
$-86.0K
$-16.8M
Free Cash Flow
BLIN
BLIN
BOLT
BOLT
Q4 25
$-46.0K
Q3 25
$-351.0K
Q2 25
$-570.0K
Q1 25
$-374.0K
Q4 24
$173.0K
Q3 24
$212.0K
$-14.0M
Q2 24
Q1 24
$-91.0K
FCF Margin
BLIN
BLIN
BOLT
BOLT
Q4 25
-1.2%
Q3 25
-9.1%
Q2 25
-14.8%
Q1 25
-9.7%
Q4 24
4.6%
Q3 24
5.5%
-1227.6%
Q2 24
Q1 24
-2.4%
Capex Intensity
BLIN
BLIN
BOLT
BOLT
Q4 25
0.2%
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
3.6%
Q2 24
0.5%
0.0%
Q1 24
0.1%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLIN
BLIN

Subscription$3.2M81%
Other$758.0K19%

BOLT
BOLT

Segment breakdown not available.

Related Comparisons